Preimplantation Genetic Diagnosis (PGD) Proven Experience
Make sure your next IVF cycle has the best chance for a successful outcome.
Natera is a pioneer in developing tests for preimplantation genetic diagnosis (PGD) performed during in-vitro fertilization. In 2008, we were the first PGD reference laboratory to offer rapid turnaround microarray PGD. Today, our tests are used in over 100 leading in-vitro fertilization clinics to identify genetic diseases and chromosomal abnormalities in embryos prior to implantation.
Our innovative approach to genetic testing leads to exceptional results – initial data from an ongoing clinical investigation demonstrates that the use of our technology doubles the rate of successful implantation.
If you are considering in-vitro fertilization, genetic testing from Natera can help to increase your chances of having a healthy child.
Parental Support™ provides the most accurate and comprehensive PGD on the market.
Natera's proprietary Parental Support™ technology combines the latest innovations in biomedical research and bioinformatic statistics to deliver highly accurate test results. This advanced bioinformatics technology can test tiny quantities of DNA – as small as that from a single cell – to comprehensively analyze genetic tissue. Parental Support uses parent DNA as reference data to compare to the embryo DNA, producing results that are far more reliable than conventional testing methods.
Parental Support technology is built into all of our products, decreasing the risk of misdiagnosis and delivering the most comprehensive genetic insights possible. With results that are typically >99% accurate, it is a technology both you and your doctor can depend on.